Literature DB >> 16103177

Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation.

Mark J Geels1, Sheri A Dubey, Kiersten Anderson, Elly Baan, Margreet Bakker, Georgios Pollakis, William A Paxton, John W Shiver, Jaap Goudsmit.   

Abstract

We aimed to identify cross-clade human immunodeficiency virus type 1 (HIV-1) specific T-cell responses among 10 HLA-typed individuals who were infected with non-B HIV-1 strains (A, AG, C, D, G, or F) and to correlate these responses with genetic variation in documented T-cell epitopes. T-cell reactivity was tested against peptide pools spanning clade B Gag, Pol, Nef, Rev, and Tat consensus, with Gag and Nef providing the highest responses. Nine individuals who responded to clade B Gag demonstrated cross-reactive T-cell responses against clade A and C Gag pools, while six of seven responders to Nef-B reacted to clade A and C Nef pools. An inverse correlation between the height of the T-cell responses and the sequence divergence of the HLA class I-restricted epitopes was identified when we compared autologous Gag and Nef sequences with the reactive consensus pools. This could be explained for the Gag sequences through observed variations in the HLA anchor residues. Through mapping of 30 amino acid cross-clade-reactive regions using Gag-B pools, we were able to link 58% (14/24) of the T-cell responses to regions containing previously described HLA class I-restricted epitopes. Forty-two percent (10/24) of the responses were directed to regions containing new epitopes, for which predicted HLA class I motifs could be recognized in 70% (7/10) of individuals. We demonstrate here that cross-clade T-cell responses are frequently induced in individuals infected with distinct HIV-1 clades, suggesting that interclade variation outside of HLA anchor residues may have less impact on vaccine-induced T-cell reactivity than previously thought.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16103177      PMCID: PMC1193573          DOI: 10.1128/JVI.79.17.11247-11258.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

3.  Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors.

Authors:  J C Gea-Banacloche; S A Migueles; L Martino; W L Shupert; A C McNeil; M S Sabbaghian; L Ehler; C Prussin; R Stevens; L Lambert; J Altman; C W Hallahan; J C de Quiros; M Connors
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.

Authors:  T Hanke; A J McMichael
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

Review 5.  Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.

Authors:  Giuseppe Pantaleo; Richard A Koup
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

Review 6.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

7.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors:  Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal:  Brief Bioinform       Date:  2004-06       Impact factor: 11.622

8.  Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primer-binding site.

Authors:  M P De Baar; A De Ronde; B Berkhout; M Cornelissen; K H Van Der Horn; A M Van Der Schoot; F De Wolf; V V Lukashov; J Goudsmit
Journal:  AIDS Res Hum Retroviruses       Date:  2000-03-20       Impact factor: 2.205

9.  Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents.

Authors:  Paul M Coplan; Swati B Gupta; Sheri A Dubey; Punnee Pitisuttithum; Alex Nikas; Bernard Mbewe; Efthyia Vardas; Mauro Schechter; Esper G Kallas; Dan C Freed; Tong-Ming Fu; Christopher T Mast; Pilaipan Puthavathana; James Kublin; Kelly Brown Collins; John Chisi; Richard Pendame; Scott J Thaler; Glenda Gray; James Mcintyre; Walter L Straus; Jon H Condra; Devan V Mehrotra; Harry A Guess; Emilio A Emini; John W Shiver
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

10.  Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.

Authors:  M E Feeney; Y Tang; K A Roosevelt; A J Leslie; K McIntosh; N Karthas; B D Walker; P J R Goulder
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more
  19 in total

1.  HIV viral diversity and escape from cellular immunity.

Authors:  Nicole Frahm; Christian Brander
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

2.  Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.

Authors:  Laura E Valentine; Shari M Piaskowski; Eva G Rakasz; Nathan L Henry; Nancy A Wilson; David I Watkins
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

Review 3.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

4.  Clade-specific evolution mediated by HLA-B*57/5801 in human immunodeficiency virus type 1 clade A1 p24.

Authors:  Lyle R McKinnon; Rupert Capina; Harold Peters; Mark Mendoza; Joshua Kimani; Charles Wachihi; Anthony Kariri; Makobu Kimani; Meika Richmond; Sandy Koesters Kiazyk; Keith R Fowke; Walter Jaoko; Ma Luo; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

5.  HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Authors:  Brandon L Guthrie; Barbara Lohman-Payne; Amy Y Liu; Rose Bosire; Samuel Victor Nuvor; Robert Y Choi; Romel D Mackelprang; James N Kiarie; Stephen C De Rosa; Barbra A Richardson; Grace C John-Stewart; Carey Farquhar
Journal:  Clin Vaccine Immunol       Date:  2012-09-12

6.  Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.

Authors:  Corey Smith; Rebekah M Brennan; Siok-Keen Tey; Mark J Smyth; Scott R Burrows; John J Miles; Geoffrey R Hill; Rajiv Khanna
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

7.  The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape.

Authors:  John T Loffredo; Benjamin J Burwitz; Eva G Rakasz; Sean P Spencer; Jason J Stephany; Juan Pablo Giraldo Vela; Sarah R Martin; Jason Reed; Shari M Piaskowski; Jessica Furlott; Kim L Weisgrau; Denise S Rodrigues; Taeko Soma; Gnankang Napoé; Thomas C Friedrich; Nancy A Wilson; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

8.  Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Authors:  Wim Jennes; Makhtar Camara; Tandakha Dièye; Souleymane Mboup; Luc Kestens
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

9.  Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany.

Authors:  Thomas Böhler; Vanessa Mrosek; Kerstin Müller; Paul Schnitzler; Martin Hartmann; Thierry Ouedraogo; Boubacar Coulibaly; Ali Sié; Vanda Bartonova; Denis M Tebit; Hans-Georg Kräusslich
Journal:  Open AIDS J       Date:  2009-01-23

10.  Epitope mapping of HIV-specific CD8+ T cells in a cohort dominated by clade A1 infection.

Authors:  Lyle R McKinnon; Xiaojuan Mao; Joshua Kimani; Charles Wachihi; Christina Semeniuk; Mark Mendoza; Binhua Liang; Ma Luo; Keith R Fowke; Francis A Plummer; T Blake Ball
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.